You are here

Article Text

Article menu
Download PDFPDF
Editorial
Xpert Ultra for diagnosing tuberculosis at bronchoscopy: thoughts on practical applications
  1. Graham Bothamley1,2,3
  1. 1 Homerton University Hospital NHS Foundation Trust, London, UK
  2. 2 Faculty of Medicine and Dentistry, Wolfson Institute of Population Health, Queen Mary University of London, London, UK
  3. 3 Facuty of Infectious and Tropical Diseaes, London School of Hygiene and Tropical Medicine, London, UK
  1. Correspondence to Professor Graham Bothamley, Homerton University Hospital NHS Foundation Trust, London, UK; g.bothamley{at}nhs.net

https://doi.org/10.1136/thorax-2024-221571

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Tests based on polymerase chain reactions are increasingly important in the microbiological diagnosis of tuberculosis (TB). Park et al1 have extended the use of Xpert Ultra to include material obtained at bronchoscopy, and particularly its use for samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). In addition, immediate cytology with rapid onsite evaluation contributed significantly to the differential diagnosis of enlarged mediastinal lymph node (MLN) disease. A review panel of the results in combination with clinical features was an important element of the study.

    In 2010, the WHO recommended that nucleic acid amplification tests (NAATs) be used to identify Mycobacterium tuberculosis (Mtb) in pulmonary and extrapulmonary TB.2 A Cochrane review noted that Xpert Ultra was better than Xpert MTB/RIF in the diagnosis of TB meningitis.3 However, aspirates from MLNs were not included in either analysis. One previous study has investigated the role of EBUS-TBNA and presented data with a diagnosis based on a combination of Xpert MTB/RIF, a positive tuberculin skin test and heterogeneity in the ultrasound texture of the MLN(s) with or without central necrosis.4

    The scientific basis underlying these NAATs will help understand their benefits and potential problems, as well as clarify areas …

    View Full Text

    Footnotes

    • Contributors None.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles